Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis
Belkıs Nihan Coşkun, Mustafa Ferhat Öksüz, Selime Ermurat, Ayşe Nur Tufan, Nurdan Oruçoğlu, Akif Doğan, Ediz Dalkılıç, Yavuz Pehlivan
(Eur J Rheumatol 2014; 1: 101-105) DOI: 10.5152/eurjrheumatol.2014.034